News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,427 Results
Type
Article (87692)
Company Profile (743)
Press Release (774974)
Multimedia
Podcasts (202)
Webinars (29)
Section
Business (232949)
Career Advice (4150)
Deals (39880)
Drug Delivery (147)
Drug Development (91265)
Employer Resources (205)
FDA (18325)
Job Trends (17433)
News (397273)
Policy (39909)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3010)
Academic (1)
Accelerated approval (34)
Adcomms (32)
Allergies (146)
Alliances (56877)
ALS (175)
Alzheimer's disease (1780)
Antibody-drug conjugate (ADC) (328)
Approvals (18499)
Artificial intelligence (522)
Autoimmune disease (176)
Automation (36)
Bankruptcy (405)
Best Places to Work (12565)
BIOSECURE Act (23)
Biosimilars (209)
Biotechnology (458)
Bladder cancer (150)
Brain cancer (58)
Breast cancer (589)
Cancer (4611)
Cardiovascular disease (354)
Career advice (3573)
Career pathing (42)
CAR-T (299)
CDC (45)
Celiac Disease (1)
Cell therapy (791)
Cervical cancer (31)
Clinical research (76618)
Collaboration (1744)
Company closure (4)
Compensation (1092)
Complete response letters (74)
COVID-19 (2947)
CRISPR (96)
C-suite (832)
Cystic fibrosis (145)
Data (5897)
Decentralized trials (2)
Denatured (75)
Depression (126)
Diabetes (398)
Diagnostics (7050)
Digital health (31)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (281)
Drug pricing (192)
Drug shortages (24)
Duchenne muscular dystrophy (240)
Earnings (98945)
Editorial (65)
Employer branding (25)
Employer resources (174)
Events (133737)
Executive appointments (927)
FDA (21068)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1377)
Gene editing (199)
Generative AI (52)
Gene therapy (632)
GLP-1 (997)
Government (5391)
Grass and pollen (6)
Guidances (324)
Healthcare (20830)
HIV (51)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (293)
Immuno-oncology (69)
Indications (105)
Infectious disease (3202)
Inflammatory bowel disease (212)
Inflation Reduction Act (14)
Influenza (109)
Intellectual property (235)
Interviews (817)
IPO (17868)
IRA (54)
Job creations (5201)
Job search strategy (2867)
JPM (68)
Kidney cancer (17)
Labor market (96)
Layoffs (649)
Leadership (40)
Legal (10120)
Liver cancer (89)
Longevity (15)
Lung cancer (637)
Lymphoma (360)
Machine learning (42)
Management (66)
Manufacturing (806)
MASH (169)
Medical device (14526)
Medtech (14562)
Mergers & acquisitions (22878)
Metabolic disorders (1190)
Multiple sclerosis (162)
NASH (23)
Neurodegenerative disease (353)
Neuropsychiatric disorders (89)
Neuroscience (3041)
Neurotech (1)
NextGen: Class of 2026 (7687)
Non-profit (5093)
Now hiring (69)
Obesity (586)
Opinion (338)
Ovarian cancer (156)
Pain (184)
Pancreatic cancer (187)
Parkinson's disease (284)
Partnered (34)
Patents (469)
Patient recruitment (460)
Peanut (59)
People (66623)
Pharmaceutical (136)
Pharmacy benefit managers (27)
Phase 1 (23710)
Phase 2 (33325)
Phase 3 (25024)
Pipeline (5011)
Policy (315)
Postmarket research (3546)
Preclinical (10634)
Press Release (72)
Prostate cancer (230)
Psychedelics (55)
Radiopharmaceuticals (293)
Rare diseases (898)
Real estate (7428)
Recruiting (81)
Regulatory (28711)
Reports (65)
Research institute (2707)
Resumes & cover letters (652)
Rett syndrome (23)
RNA editing (21)
RSV (72)
Schizophrenia (145)
Series A (237)
Series B (178)
Service/supplier (25)
Sickle cell disease (94)
Special edition (28)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4332)
State (2)
Stomach cancer (15)
Supply chain (95)
Tariffs (94)
The Weekly (125)
Vaccines (1068)
Venture capital (95)
Weight loss (385)
Women's health (82)
Worklife (22)
Date
Today (122)
Last 7 days (499)
Last 30 days (2077)
Last 365 days (27710)
2026 (3639)
2025 (28071)
2024 (35399)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1283)
Alabama (90)
Alaska (6)
Arizona (297)
Arkansas (9)
Asia (51382)
Australia (9035)
California (10434)
Canada (3031)
China (1137)
Colorado (378)
Connecticut (430)
Delaware (311)
Europe (117794)
Florida (1465)
Georgia (291)
Hawaii (4)
Idaho (65)
Illinois (836)
India (65)
Indiana (469)
Iowa (22)
Japan (402)
Kansas (135)
Kentucky (34)
Louisiana (20)
Maine (60)
Maryland (1361)
Massachusetts (7836)
Michigan (265)
Minnesota (496)
Mississippi (5)
Missouri (99)
Montana (30)
Nebraska (29)
Nevada (114)
New Hampshire (61)
New Jersey (2914)
New Mexico (31)
New York (2737)
North Carolina (1529)
North Dakota (10)
Northern California (5050)
Ohio (278)
Oklahoma (18)
Oregon (51)
Pennsylvania (2128)
Puerto Rico (24)
Rhode Island (42)
South America (1664)
South Carolina (18)
South Dakota (1)
Southern California (4098)
Tennessee (104)
Texas (1526)
United States (37171)
Utah (222)
Vermont (1)
Virginia (258)
Washington D.C. (73)
Washington State (896)
West Virginia (3)
Wisconsin (102)
Wyoming (1)
863,427 Results for "sk bio pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 3, 2026
·
5 min read
Press Releases
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026
·
4 min read
Press Releases
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
·
5 min read
Press Releases
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion
December 15, 2025
·
4 min read
Press Releases
SK pharmteco and LOTTE BIOLOGICS Sign Strategic Partnership to Strengthen Global ADC CDMO Capabilities
October 30, 2025
·
3 min read
Press Releases
SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation
November 27, 2025
·
6 min read
Press Releases
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
June 2, 2025
·
6 min read
Press Releases
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform
October 21, 2025
·
13 min read
Press Releases
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
May 30, 2025
·
7 min read
Press Releases
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
May 14, 2025
·
6 min read
1 of 86,343
Next
